SB425 Alabama 2019 Session
Signed by Governor
Bill Summary
Sponsors
Session
Regular Session 2019
Title
Health care, treatment guidelines relating to buprenorphine, review committee established to aid in rule drafting
Description
This bill would establish guidelines for the use of buprenorphine in nonresidential treatment programs.
This bill would also provide for the adoption of rules to further implement and enforce the provisions of the act.
Relating to health care; to establish guidelines for the use of buprenorphine in nonresidential treatment programs; and to provide for the adoption of rules to further implement and enforce the provisions of the act.
Subjects
Health
Bill Actions
| Action Date | Chamber | Action |
|---|---|---|
| May 31, 2019 | S | Assigned Act No. 2019-500. |
| May 31, 2019 | H | Signature Requested |
| May 31, 2019 | S | Enrolled |
| May 31, 2019 | S | Passed Second House |
| May 31, 2019 | H | Motion to Read a Third Time and Pass adopted Roll Call 1282 |
| May 31, 2019 | H | Third Reading Passed |
| May 29, 2019 | H | Read for the second time and placed on the calendar |
| May 28, 2019 | H | Read for the first time and referred to the House of Representatives committee on Health |
| May 28, 2019 | S | Motion to Read a Third Time and Pass adopted Roll Call 1237 |
| May 28, 2019 | S | Third Reading Passed |
| May 23, 2019 | S | Read for the second time and placed on the calendar |
| May 22, 2019 | S | Read for the first time and referred to the Senate committee on Finance and Taxation General Fund |
Bill Text
Bill Votes
Bill Documents
| Type | Link |
|---|---|
| Bill Text | SB425 Alabama 2019 Session - Enrolled |
| Bill Text | SB425 Alabama 2019 Session - Introduced |
Source: Alabama Legislature